ESVAX Fees and Costs — Eaton Vance Global Small-Cap Equity Fund, Class A
Data updated: 2023-09-29
The net expense ratio is 1.35%: a 0.90% management fee, a 0.25% 12b-1 fee plus 0.68% other expenses, less a 0.48% fee waiver. This share class carries a maximum front-end sales load of 5.25%. In fiscal 2022 the fund paid $14K in broker commissions, 0.0424% of average net assets, and portfolio turnover was 45%.
ESVAX Fees and Expenses
Annual operating expenses and sales charges of ESVAX. Prospectus, as of October 31, 2022.
| Annual operating expenses | |
|---|---|
| Management fee | 0.90% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.68% |
| Gross expense ratio | 1.83% |
| Fee waiver | −0.48% |
| Net expense ratio | 1.35% |
| Sales charges | |
|---|---|
| Max front load | 5.25% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
ESVAX Costs Over Time
On $10,000 invested in ESVAX, assuming 5% a year before costs, total costs come to $1,489 over 5 years, cutting the return by 2.57% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $525 | $525 | $525 |
| Fund expenses (net expense ratio 1.35%) | $134 | $417 | $721 |
| Trading costs (broker commissions) | $4 | $13 | $23 |
| Lost growth on money paid in costs | $26 | $104 | $220 |
| Total costs | $690 | $1,060 | $1,489 |
| Value after costs | $9,810 | $10,517 | $11,274 |
| Impact on return, per year | 6.90% | 3.31% | 2.57% |
ESVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2022.
- Explicit cost rate (commissions ÷ average net assets): 0.0424%
- Total broker commissions: $14K
- Bought from dealers (principal trades, not a cost): $5.9M
- Portfolio turnover (prospectus): 45%
- Securities lending: none during the year
ESVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Instinet, LLC | $2K | 19.14% |
| UBS Securities LLC | $2K | 14.53% |
| SMBC Nikko Securities America, Inc. | $1K | 13.07% |
| RBC Capital Markets, LLC | $1K | 11.96% |
| Virtu Americas LLC | $914 | 8.82% |
| BofA Securities, Inc. | $775 | 7.48% |
| Credit Suisse Securities (USA) LLC | $721 | 6.95% |
| Berenberg Capital Markets LLC | $680 | 6.55% |
| Daiwa Capital Markets America Inc. | $621 | 5.99% |
| J.P. Morgan Securities LLC | $571 | 5.50% |
ESVAX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| State Street Global Markets, LLC | $5.9M | 100.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.